Cervix cancer
Conditions
Interventions
Cervical cancer screening by using cytology testing alone as a standard screening modality(following up over 7 years)
Cervical cancer screening by using cytology testing plus HPV testing as an experim
Sponsors
School of Medicine, Keio University
Japan Cancer Society, public interest foundation
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1) Women aged 30-49 years old who have a screening of cervical cancer 2) Participants provided informed consent.
Exclusion criteria
Exclusion criteria: 1)Women who have had invasive cervical cancer before. 2)Women who have underwent surgery of uterine cervix (cervical conization). 3)Women who have underwent hysterectomy. 4)Women who have had or have CIN or the cytological abnormalities and are under follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The incidence of CIN3 or worse during whole periods | — |
Secondary
| Measure | Time frame |
|---|---|
| The incidence both of CIN3 and of CIN2 or worse during whole periods The morbidity incidence rate of invasive cervical cancer, cumulative incidence of invasive cervical cancer The frequency of examinations and accidental symptoms during whole periods | — |
Countries
Japan
Contacts
Public ContactYasuo Ohasi
Japan Clinical Research Support Unit (J-CRSU) Clinical Research Call Center
Outcome results
None listed